Investment Success in Public Health: An Analysis of the Cost-Effectiveness and Cost-Benefit of the Global Programme to Eliminate Lymphatic Filariasis

BACKGROUND. It has been estimated that $154 million per year will be required during 2015–2020 to continue the Global Programme to Eliminate Lymphatic Filariasis (GPELF). In light of this, it is important to understand the program’s current value. Here, we evaluate the cost-effectiveness and cost-be...

Descripción completa

Detalles Bibliográficos
Autores principales: Turner, Hugo C., Bettis, Alison A., Chu, Brian K., McFarland, Deborah A., Hooper, Pamela J., Mante, Sunny D., Fitzpatrick, Christopher, Bradley, Mark H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2017
Materias:
Major Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5404931/
https://www.ncbi.nlm.nih.gov/pubmed/27956460
http://dx.doi.org/10.1093/cid/ciw835

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5404931/
https://www.ncbi.nlm.nih.gov/pubmed/27956460
http://dx.doi.org/10.1093/cid/ciw835

Ejemplares similares